...also shelter income from marketed Cephalon products either through its existing Swiss presence or through Mepha AG...

...to $101.6M from $34.2M. The company attributed the rise to the acquisition of generics company Mepha AG...

...The pace did not slow in his last year, with the acquisitions of generics company Mepha AG...
...was. I had a quiet moment with his management team and complimented them on the Mepha...

...its previously announced acquisition of generics company Mepha for CHF662.4 million ($623.4 million) in cash. Mepha...
...a wholly owned subsidiary of Cephalon (see BioCentury, Feb. 8). Cephalon Inc. (NASDAQ:CEPH), Frazer, Pa. Mepha AG...

...billion and EPS of $6.80-$7. The 2010 estimates assume that the acquisition of generics company Mepha AG...

...NASDAQ:CEPH) was up $0.64 to $64.48 last week after saying it will acquire generics company Mepha AG...

...Cephalon Inc. Chairman and CEO Frank Baldino says the company's proposed acquisition of generics company Mepha AG...
...the years, and our European business, which included branded generics, helped to drive that growth. Mepha...
...added. Last week, Cephalon proposed to acquire Mepha for CHF622.5 million ($587.9 million) in cash. Mepha's...

...Cephalon announced on Feb. 1 that it will acquire generics company Mepha for CHF622.5 million ($587.9...
...size of its international presence, expanding its reach in Europe, Africa and the Middle East. Mepha...
...which is expected to close in the next 10-12 weeks. Cephalon Inc. (NASDAQ:CEPH), Frazer, Pa. Mepha AG...

...Cephalon Inc. (NASDAQ:CEPH) will acquire generics company Mepha AG (Basel, Switzerland) for CHF622.5 million ($587.9 million) in...
...size of its international business, expanding its reach in Europe, Africa and the Middle East. Mepha...

...oral alpha adrenergic stimulant to treat narcolepsy. CEPH licensed Swiss rights to the compound from Mepha...